If you haven't heard about the report in December's Journal of Vascular Sciences by Italian vascular surgeon Dr. Paolo Zamboni, then you probably live in America.
The vaccine incorporates the sequence of myelin basic protein (MBP), which is thought to be one of the targets of MS, and DNA is incorporated into the cells in the body, which then starts to make the protein.
A revolutionary surgery that involves drilling a hole in the skull and injecting cells could repair some devastating effects of multiple sclerosis.
"We have shown for the first time that immediate treatment after a first clinical demyelinating event suggestive of MS can reduce the early neurological damage, which may ultimately delay the development of the debilitating sequelae that characterize adv
The new peptides have been found to be more effective than Copaxone® in in-vitro and in-vivo assays, as well as in animal disease models of MS.
Merck Serono announced today that it has begun the ONWARD (Oral Cladribine Added ON To Rebif New Formulation in Patients With Active Relapsing Disease) Phase II study.
The first study examining the relationship between parasite infections and multiple sclerosis in humans suggests that such infections may affect the immune response in a way that alters the course of MS.
Merck Serono announced today that patient enrollment has been completed in the CLARITY (CLAdRIbine Tablets Treating MS OrallY) study, a Phase III pivotal clinical trial evaluating the efficacy and safety
Researchers at the Roslin Institute in Edinburgh have genetically engineered chickens that could one day produce medicines to fight diseases like cancer and multiple sclerosis in their eggs.
People with multiple sclerosis are backing a Norfolk and Norwich University Hospital study into whether cannabis will help them cope with the condition.
Created especially for the public, SearchClinicalTrials.org allows you to search multiple websites for clinical trial listings, results, and publications at one time. Search by Disease or Condition, Location, Sponsor, Age, Phase, and much more.
Women who took COPAXONE® (glatiramer acetate injection) during part of their pregnancies demonstrated no more risk than the general population of pregnancy outcomes, according to an abstract presented this week at the American Academy of Neurology (AAN).
Generic drug maker Teva Pharmaceutical Industries Ltd. said Monday new data from a study of its multiple sclerosis drug reinforce previous information that the treatment reduces relapses of symptoms and may slow tissue damage associated with the disease.
Researchers report that the safety and tolerability of Novantrone (mitoxantrone) in long-term treatment of worsening multiple sclerosis appears to be consistent with its known safety profile.
Treatment of relapsing-remitting multiple sclerosis (MS) with glatiramer-acetate (glatiramer, Copaxone) is safe and effective, and it has a positive impact on average relapse rate and disease progression scores.
